Summary
Perlecan domain V (DV) may improve functional stroke outcome. This article discusses findings from a study that investigated the effect of the extracellular matrix fragment perlecan domain V on angiogenesis and neurogenesis in poststroke rats and mice.
- neurology
- cerebrovascular disease
- neurology clinical trials
- © 2010 MD Conference Express